Deltha Pharma is Growth Leader 2024 and among “100 Excellences of Italy”.
Deltha Pharma is Growth Leader 2024 for Il Sole 24 Ore. Immediately after the recognition by La Repubblica Affari e Finanza and the German ITQF Institute as Growth Champion comes a new confirmation from the national business community.
Leader of Growth 2024 is the list of the 500 Italian companies with the highest turnover growth between 2019 and 2022, compiled by Sole 24 Ore and Statista.
Growth Leader is just the latest in a year in which the Italian and international business community has understood and promoted the ideals and work of Deltha Pharma.
What’s more?
On 30th November, the 100 Excellences of Italy award ceremony took place in the beautiful setting of the Sala della Regina in Palazzo Montecitorio, Chamber of Deputies of the Italian Republic.
On this occasion Deltha Pharma received the award for Excellence in the Food Supplements category as a corollary to a 2023 full of achievements and awards received.
The event was attended by the protagonists of all the one hundred success stories representative of the sectors of Economy, Science, Arts, Sport, Social and Public Administration, selected by the italian publishing house RDE under the supervision of a prestigious Committee of Honour and recounted in the volume 100 Italian Excellences, soon to be published.
The ceremony-event, presented by the Italian journalist and TV presenter Alda D’Eusanio, enjoyed the patronage of the Presidency of the Council of Ministers, eleven Ministries and three other Institutional Bodies, as well as the introductory greetings of Chamber of Deputies Vice President Mr. Giorgio Mulè.
For Deltha Pharma this is a new award (after the Italian Excellence Award for LeFonti and the Awards from the Italian Journal Repubblica Affari and Finanza as Growth Leaders and Il Sole 24 Ore as Growth Champions) in this 2023. The award recognises years of work, research, and refinement in both innovation and the company’s sustainable approach. Just a few days ago, our Sustainability Report was published, listing all the activities carried out and those in progress to improve the company from an ESG perspective.
Closing the year 2023 as one of the 100 Stories of Excellence is for us at Deltha Pharma and for our CEO Eng. Maria Francesca Aceti a source of pride and a spur to further improve our quality standards to improve the quality of life of people and the environment both through our products and our work ethics.